(Circulation. 1999;99:E12.)
© 1999 American Heart Association, Inc.
Circulation Electronic Pages |
From the Department of Medicine (Cardiovascular Medicine), Albert Einstein College of Medicine, Bronx, NY.
Correspondence to David L. Brown, MD, Division of Cardiovascular Medicine, Albert Einstein College of Medicine, 1825 Eastchester Rd, Bronx, NY 10461. E-mail dbrown{at}montefiore.org
BackgroundThis study seeks to analyze changes in the practice of PTCA in California between 1989 and 1995 by use of the Office of Statewide Health Planning and Development (OSHPD) data set.
Methods and ResultsAll hospital discharges in 1995 with a
procedure code for PTCA or stent were identified. The 1995 PTCA data
were compared with previously published data from 1989 obtained from
the same database. The number of PTCAs performed increased by 49%
between 1989 and 1995, from 24 883 to 37 118. The percentage of
female patients increased from 29.8% to 32.7%
(P=0.0001). The percentage of diabetics increased from
14.4% to 21.6% (P=0.0001) between 1989 and 1995.
Procedures on patients with a principal diagnosis of acute myocardial
infarction increased from 19.3% of all PTCAs in 1989 to 27.5% of
PTCAs in 1995 (P=0.0001). In-hospital mortality
increased from 1.4% in 1989 to 1.9% in 1995
(P=0.0001). There were 3087 admissions with stent
placement in 1995. In-hospital mortality after stent placement was
0.9% (P=0.0001 versus PTCA). Patients undergoing PTCA
in hospitals performing >400 PTCAs in 1995 had a 4% incidence of
death or emergency bypass surgery compared with a 6% incidence when
PTCAs were performed in hospitals performing
400 PTCA in 1995
(P<0.0001). Patients undergoing stent implantation in
hospitals performing >75 stent procedures in 1995 had a 1.3%
incidence of death or emergency bypass compared with an incidence of
4% when the procedure was performed in a hospital performing
75
stent placements in 1995 (P<0.0001).
ConclusionsThe 1995 OSHPD data continue to suggest an inverse relationship between hospital PTCA and stent volume and adverse patient outcomes.
Key Words: angioplasty stents prognosis
This article has been cited by other articles:
![]() |
S. M. Kansagra, L. H. Curtis, and K. A. Schulman Regionalization of Percutaneous Transluminal Coronary Angioplasty and Implications for Patient Travel Distance JAMA, October 13, 2004; 292(14): 1717 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Epstein, S. S. Rathore, K. G. M. Volpp, and H. M. Krumholz Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: Does the evidence support current procedure volume minimums? J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1755 - 1762. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |